Rennova Health, Inc. (RNVA)
OTCMKTS: RNVA · Delayed Price · USD
0.0000
-0.0001 (-99.00%)
May 3, 2024, 3:56 PM EDT - Market closed
Rennova Health Revenue
Rennova Health had revenue of $20.30M in the twelve months ending September 30, 2023, with 113.44% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $3.54M with 25.20% year-over-year growth. In the year 2022, Rennova Health had annual revenue of $13.04M with 304.36% growth.
Revenue (ttm)
$20.30M
Revenue Growth
+113.44%
P/S Ratio
0.00
Revenue / Employee
$238,855
Employees
85
Market Cap
43.05K USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2022 | 13.04M | 9.81M | 304.36% |
Dec 31, 2021 | 3.22M | -3.98M | -55.22% |
Dec 31, 2020 | 7.20M | -8.79M | -54.96% |
Dec 31, 2019 | 15.99M | 1.44M | 9.89% |
Dec 31, 2018 | 14.55M | 9.93M | 214.94% |
Dec 31, 2017 | 4.62M | -625.64K | -11.93% |
Dec 31, 2016 | 5.25M | -13.15M | -71.48% |
Dec 31, 2015 | 18.39M | 17.90M | 3,593.38% |
Mar 31, 2015 | 498.00K | -160.00K | -24.32% |
Mar 31, 2014 | 658.00K | 258.00K | 64.50% |
Mar 31, 2013 | 400.00K | 300.00K | 300.00% |
Mar 31, 2012 | 100.00K | 84.00K | 525.00% |
Mar 31, 2011 | 16.00K | -12.38M | -99.87% |
Mar 31, 2010 | 12.40M | -672.00K | -5.14% |
Mar 31, 2009 | 13.07M | -19.86M | -60.30% |
Mar 31, 2008 | 32.93M | 10.66M | 47.89% |
Mar 31, 2007 | 22.26M | 506.00K | 2.33% |
Mar 31, 2006 | 21.76M | 6.87M | 46.14% |
Mar 31, 2005 | 14.89M | -1.64M | -9.92% |
Mar 31, 2004 | 16.53M | 2.43M | 17.22% |
Mar 31, 2003 | 14.10M | -7.51M | -34.74% |
Mar 31, 2002 | 21.61M | -16.60M | -43.45% |
Mar 31, 2001 | 38.21M | 11.77M | 44.51% |
Mar 31, 2000 | 26.44M | -2.56M | -8.83% |
Mar 31, 1999 | 29.00M | -12.50M | -30.12% |
Mar 31, 1998 | 41.50M | -15.90M | -27.70% |
Mar 31, 1997 | 57.40M | -4.60M | -7.42% |
Mar 31, 1996 | 62.00M | 17.40M | 39.01% |
Mar 31, 1995 | 44.60M | 6.58M | 17.31% |
Mar 31, 1994 | 38.02M | -4.76M | -11.13% |
Mar 31, 1993 | 42.78M | 620.00K | 1.47% |
Mar 31, 1992 | 42.16M | 1.17M | 2.85% |
Mar 31, 1991 | 40.99M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 81.80B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.33B |
RNVA News
- 5 weeks ago - RENNOVA HEALTH, INC., ANNOUNCES THE EXPIRATION OF WARRANTS TO PURCHARE OVER FOUR HUNDRED BILLION COMMON SHARES - GlobeNewsWire
- 3 months ago - RENNOVA HEALTH, INC. CEO PROVIDES JANUARY 2024 MESSAGE TO SHAREHOLDERS - GlobeNewsWire
- 6 months ago - RENNOVA HEALTH, INC. ANNOUNCES SIGNIFICANT DEBT RESTRUCTURING - GlobeNewsWire
- 9 months ago - RENNOVA HEALTH, INC. PROVIDES UPDATE AFTER FILING 2023 SECOND QUARTER FINANCIAL STATEMENTS - GlobeNewsWire
- 9 months ago - RENNOVA HEALTH, INC. ANNOUNCES THE OPENING OF ITS FIRST ALCOHOL AND DRUG TREATMENT FACILITY - GlobeNewsWire
- 11 months ago - RENNOVA HEALTH, INC. ANNOUNCES THE EXPANSION OF SERVICES AT ITS BIG SOUTH FORK MEDICAL CENTER HOSPITAL, TO INCLUDE SWING BEDS. - GlobeNewsWire
- 1 year ago - RENNOVA HEALTH, INC. PROVIDES UPDATE AFTER FILING 2022 FINANCIAL STATEMENTS - GlobeNewsWire
- 1 year ago - RENNOVA HEALTH, INC. PROVIDES UPDATE ON 2022 FINANCIALS AND MYRTLE RECOVERY CENTERS - GlobeNewsWire